Cite

HARVARD Citation

    Maffei, R. et al. (2016). Lenalidomide in chronic lymphocytic leukemia: the present and future in the era of tyrosine kinase inhibitors. Critical reviews in oncology/hematology. pp. 291-302. [Online]. 
  
Back to record